| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.85M | 8.05M | 3.69M | 6.10M | 5.23M |
| Gross Profit | 4.08M | 5.24M | -20.63M | 4.38M | -3.28M |
| EBITDA | -66.61M | -38.86M | -33.28M | -46.18M | -12.04M |
| Net Income | -74.82M | -46.25M | -38.08M | -51.86M | -13.45M |
Balance Sheet | |||||
| Total Assets | 226.10M | 263.34M | 189.59M | 302.98M | 202.86M |
| Cash, Cash Equivalents and Short-Term Investments | 42.56M | 78.63M | 73.93M | 142.74M | 136.66M |
| Total Debt | 70.42M | 132.83M | 40.37M | 41.41M | 10.27M |
| Total Liabilities | 88.51M | 83.74M | 51.37M | 51.85M | 24.68M |
| Stockholders Equity | 137.59M | 183.94M | 151.39M | 251.13M | 178.18M |
Cash Flow | |||||
| Free Cash Flow | -70.32M | -55.42M | -29.65M | -113.02M | -25.66M |
| Operating Cash Flow | -40.42M | -36.23M | -12.89M | -29.23M | -6.09M |
| Investing Cash Flow | -18.17M | -11.74M | -16.10M | -106.80M | -19.68M |
| Financing Cash Flow | 25.21M | 29.31M | -531.57K | 180.69M | 103.77M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | AU$210.88M | 53.61 | 12.33% | 0.74% | 24.67% | 96.27% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | AU$108.59M | 33.33 | 5.66% | 1.28% | -14.88% | -56.89% | |
46 Neutral | AU$99.23M | -15.35 | -16.49% | ― | ― | -40.28% | |
45 Neutral | AU$365.43M | -2.30 | -45.24% | ― | -12.84% | -29.62% |
NOVONIX Limited has announced the application for quotation of 18,833 fully paid ordinary securities on the Australian Securities Exchange (ASX). This step reflects the company’s ongoing efforts to align with its strategic goals, potentially enhancing its market presence and providing additional opportunities for stakeholders.
The most recent analyst rating on (AU:NVX) stock is a Hold with a A$0.45 price target. To see the full list of analyst forecasts on NOVONIX Ltd stock, see the AU:NVX Stock Forecast page.
NOVONIX Ltd has announced the appointment of Mike O’Kronley as a director, effective December 15, 2025. As part of his appointment, O’Kronley holds 3,723,971 performance rights, indicating a significant stake in the company’s future performance. This move is expected to strengthen NOVONIX’s leadership team and potentially enhance its strategic direction in the competitive battery materials industry.
The most recent analyst rating on (AU:NVX) stock is a Hold with a A$0.45 price target. To see the full list of analyst forecasts on NOVONIX Ltd stock, see the AU:NVX Stock Forecast page.
NOVONIX Limited has announced the appointment of its CEO, Mike O’Kronley, as Managing Director, effective December 15, 2025. This move is expected to enhance the company’s strategic execution and governance framework, aligning with its goals of strengthening board oversight. The appointment underscores NOVONIX’s commitment to its strategic objectives and may positively impact its operations and industry positioning.
The most recent analyst rating on (AU:NVX) stock is a Hold with a A$0.45 price target. To see the full list of analyst forecasts on NOVONIX Ltd stock, see the AU:NVX Stock Forecast page.
NOVONIX Limited has announced the issuance of 489,818 performance rights under an employee incentive scheme. These unquoted securities are not intended to be listed on the ASX, reflecting the company’s strategy to incentivize its workforce and potentially align employee interests with corporate goals.
The most recent analyst rating on (AU:NVX) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on NOVONIX Ltd stock, see the AU:NVX Stock Forecast page.
NOVONIX Ltd has achieved significant milestones, including delivering its first mass production sample of synthetic graphite and completing the installation of mass production equipment for Panasonic. The company has also been selected for a grant from Natural Resources Canada and has been advancing its patented cathode technology. Additionally, NOVONIX has secured substantial funding through convertible debentures with Yorkville Advisors, completed strategic sales, and made key executive appointments, positioning itself strongly in the battery materials market.
The most recent analyst rating on (AU:NVX) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on NOVONIX Ltd stock, see the AU:NVX Stock Forecast page.
NOVONIX Limited has achieved a significant operational milestone by delivering its first mass production, commercial-grade sample of synthetic graphite for industrial applications to a major North American carbon processor. This accomplishment demonstrates the capability of NOVONIX’s proprietary continuous graphitization furnace technology to produce industrial-grade products at scale. The Riverside facility is set to become the first large-scale production site for high-performance synthetic graphite in North America, with mass production starting next year for Panasonic. The company plans to expand its production capacity with a second plant in Chattanooga, aiming for a total capacity of over 50,000 tonnes per year, which will enhance its market positioning and meet growing customer demand.
The most recent analyst rating on (AU:NVX) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on NOVONIX Ltd stock, see the AU:NVX Stock Forecast page.